drugset / Trial / NCT01082562
Safety Study of BMS-844421 for Treatment of Hypercholesterolemia
RandomizedSingle-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability, serum concentrations and pharmacodynamic effects on serum low-density lipoprotein (LDL) cholesterol of single and multiple subcutaneous and intravenous doses of BMS-844421 in healthy subjects (SAD) and in subjects with elevated cholesterol (MAD).
Timeline
- Start
- 2010-04
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-844421 | Unknown | 37.5 mg | Subcutaneous |